Eli Lilly Updates Debt Instruments in 8-K Filing

Ticker: LLY · Form: 8-K · Filed: 2024-02-09T00:00:00.000Z

Sentiment: neutral

Topics: debt, corporate-finance, 8-K

TL;DR

**Eli Lilly just updated its long-term debt details, showing various notes due through 2061.**

AI Summary

Eli Lilly and Company filed an 8-K on February 9, 2024, reporting an "Other Event" that occurred on February 7, 2024. This filing primarily updates the company's outstanding debt instruments, specifically detailing various notes with maturity dates ranging from June 1, 2025, to 2061, and interest rates from 1.125% to 6.77%. This matters to investors because it provides transparency on the company's long-term financial obligations, which can impact future earnings and cash flow available for shareholders.

Why It Matters

This filing provides a clear picture of Eli Lilly's long-term debt structure, which is crucial for assessing the company's financial health and its ability to manage future interest payments.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of existing debt instruments and does not indicate any new, significant financial risk or change in the company's operations.

Analyst Insight

A smart investor would review Eli Lilly's full financial statements to understand the total debt burden relative to its assets and cash flow, rather than just these specific notes, to assess long-term solvency.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 7, 2024.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on February 9, 2024.

What is the range of maturity dates for the notes mentioned in the filing?

The notes mentioned in the filing have maturity dates ranging from June 1, 2025, to 2061.

What is the highest interest rate noted on the debt instruments in this filing?

The highest interest rate noted is 6.77% for notes due January 1, 2036.

What is the lowest interest rate noted on the debt instruments in this filing?

The lowest interest rate noted is 1.125% for notes due 2051.

From the Filing

0001193125-24-029551.txt : 20240209 0001193125-24-029551.hdr.sgml : 20240209 20240209115635 ACCESSION NUMBER: 0001193125-24-029551 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 23 CONFORMED PERIOD OF REPORT: 20240207 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 24613349 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 8-K 1 d728700d8k.htm 8-K 8-K ELI LILLY & Co false 0000059478 0000059478 2024-02-07 2024-02-07 0000059478 us-gaap:CommonClassAMember 2024-02-07 2024-02-07 0000059478 lly:A718NotesDueJune12025Member 2024-02-07 2024-02-07 0000059478 lly:A1.625NotesDueJune22026Member 2024-02-07 2024-02-07 0000059478 lly:A2.125NotesDueJune32030Member 2024-02-07 2024-02-07 0000059478 lly:A625Notesdue2031Member 2024-02-07 2024-02-07 0000059478 lly:A500NotesDue2033Member 2024-02-07 2024-02-07 0000059478 lly:A6.77NotesDueJanuary12036Member 2024-02-07 2024-02-07 0000059478 lly:A1625NotesDue2043Member 2024-02-07 2024-02-07 0000059478 lly:A1.700Notesdue2049Member 2024-02-07 2024-02-07 0000059478 lly:A1125NotesDue2051Member 2024-02-07 2024-02-07 0000059478 lly:A1375NotesDue2061Member 2024-02-07 2024-02-07     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 7, 2024     ELI LILLY AND COMPANY (Exact Name of Registrant as Specified in its Charter)       Indiana   001-06351   35-0470950 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   Lilly Corporate Center Indianapolis , Indiana   46285 (Address of Principal Executive Offices)   (Zip Code) Registrant’s Telephone Number, Including Area Code: (317) 276-2000 Not Applicable (Former Name or Former Address, if Changed Since Last Report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2.):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock (no par value)   LLY   New York Stock Exchange 7 1/8% Notes due 2025   LLY25   New York Stock Exchange 1.625% Notes due 2026   LLY26   New York Stock Exchange 2.125% Notes due 2030   LLY30   New York Stock Exchange 0.625% Notes due 2031   LLY31   New York Stock Exchange 0.500% Notes due 2033   LLY33   New York Stock Exchange 6.77% Notes due 2036   LLY36   New York Stock Exchange 1.625% Notes due 2043

View on Read The Filing